<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Dev Biol</journal-id><journal-title>BMC Developmental Biology</journal-title><issn pub-type="epub">1471-213X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-213X-8-75</article-id><article-id pub-id-type="pmid">18667074</article-id><article-id pub-id-type="doi">10.1186/1471-213X-8-75</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title><italic>Msx1 </italic>and <italic>Msx2 </italic>are required for endothelial-mesenchymal transformation of the atrioventricular cushions and patterning of the atrioventricular myocardium</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Chen</surname><given-names>Yi-Hui</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><email>yihuiche@gate.sinica.edu.tw</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Ishii</surname><given-names>Mamoru</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ishii@usc.edu</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Sucov</surname><given-names>Henry M</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>sucov@usc.edu</email></contrib><contrib id="A4" corresp="yes" contrib-type="author"><name><surname>Maxson</surname><given-names>Robert E</given-names><suffix>Jr</suffix></name><xref ref-type="aff" rid="I1">1</xref><email>maxson@usc.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Biochemistry and Molecular Biology, USC/Norris Comprehensive Cancer Center and Hospital, Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, University of Southern California, Los Angeles, CA 90089-9176, USA</aff><aff id="I2"><label>2</label>Institute for Genetic Medicine, Keck School of Medicine, University of Southern California, 2250 Alcazar Street, Suite 240, Los Angeles, CA 90089-9075, USA</aff><aff id="I3"><label>3</label>Stem Cell Laboratories, Genomics Research Center, Acadmia Sinica, Taipei 11529, Taiwan </aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>30</day><month>7</month><year>2008</year></pub-date><volume>8</volume><fpage>75</fpage><lpage>75</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-213X/8/75"/><history><date date-type="received"><day>13</day><month>12</month><year>2007</year></date><date date-type="accepted"><day>30</day><month>7</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Chen et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Chen et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Chen Yi-Hui yihuiche@gate.sinica.edu.tw </dc:author><dc:title> Msx1 and Msx2 are required for endothelial-mesenchymal transformation of the atrioventricular cushions and patterning of the atrioventricular myocardium </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>BMC Developmental Biology 8(1): 75-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-213X(2008)8:1&#x0003c;75&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-213X</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p><italic>Msx1 </italic>and <italic>Msx2</italic>, which belong to the highly conserved <italic>Nk </italic>family of homeobox genes, display overlapping expression patterns and redundant functions in multiple tissues and organs during vertebrate development. <italic>Msx1 </italic>and <italic>Msx2 </italic>have well-documented roles in mediating epithelial-mesenchymal interactions during organogenesis. Given that both <italic>Msx1 </italic>and <italic>Msx2 </italic>are crucial downstream effectors of Bmp signaling, we investigated whether <italic>Msx1 </italic>and <italic>Msx2 </italic>are required for the Bmp-induced endothelial-mesenchymal transformation (EMT) during atrioventricular (AV) valve formation.</p></sec><sec><title>Results</title><p>While both <italic>Msx1-/- </italic>and <italic>Msx2-/- </italic>single homozygous mutant mice exhibited normal valve formation, we observed hypoplastic AV cushions and malformed AV valves in <italic>Msx1-/-; Msx2-/- </italic>mutants, indicating redundant functions of <italic>Msx1 </italic>and <italic>Msx2 </italic>during AV valve morphogenesis. In <italic>Msx1/2 </italic>null mutant AV cushions, we found decreased Bmp2/4 and <italic>Notch1 </italic>signaling as well as reduced expression of <italic>Has2</italic>, <italic>NFATc1 </italic>and <italic>Notch1</italic>, demonstrating impaired endocardial activation and EMT. Moreover, perturbed expression of chamber-specific genes <italic>Anf</italic>, <italic>Tbx2</italic>, <italic>Hand1 </italic>and <italic>Hand2 </italic>reveals mispatterning of the <italic>Msx1/2 </italic>double mutant myocardium and suggests functions of <italic>Msx1 </italic>and <italic>Msx2 </italic>in regulating myocardial signals required for remodelling AV valves and maintaining an undifferentiated state of the AV myocardium.</p></sec><sec><title>Conclusion</title><p>Our findings demonstrate redundant roles of <italic>Msx1 </italic>and <italic>Msx2 </italic>in regulating signals required for development of the AV myocardium and formation of the AV valves.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>A complex series of morphogenetic events and hemodynamic influences are required for cardiogenesis [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. Malformations of cardiac valves constitute the most prevalent form of human birth defects, appearing in nearly one percent of newborn infants [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. The formation of cardiac valves requires two major consecutive steps: cardiac cushion formation and valve remodeling [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. After cardiac looping, the cardiac cushions in the regions of the atrioventricular (AV) canal and distal outflow tract (OFT) are formed through an endothelial-mesenchymal transformation (EMT), a remarkably complex event initiated by the specification and activation of a subset of endothelial cells in the cushion-forming regions. This event is followed by cell delamination from the endocardium and cell migration into the extracellular matrix between the endocardium and myocardium (referred to as the cardiac jelly) [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. Concomitant with migration into the cardiac jelly, the endothelial cells transdifferentiate into mesenchymal cells and proliferate to form multiple layers, resulting in the expansion of the cushion crests toward each other [<xref ref-type="bibr" rid="B6">6</xref>]. AV cushion formation is followed by a series of morphogenetic events, including elongation, outgrowth and remodeling, which result in the conversion of the thick cushions into thin valve leaflets [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. Several signaling molecules have been implicated in regulating EMT during cardiac valve formation, including the Nuclear Factor in Activated T cells (NFAT) [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B12">12</xref>], Vascular Endothelial Growth Factor (VEGF) [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B13">13</xref>], and members of the Epidermal Growth Factor (EGF) [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>], Bone Morphogenetic Protein (Bmp) [<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B19">19</xref>], Notch [<xref ref-type="bibr" rid="B20">20</xref>-<xref ref-type="bibr" rid="B22">22</xref>], Transforming Growth Factor-&#x003b2; (TGF-&#x003b2;) [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B23">23</xref>], and Wnt/&#x003b2;-catenin families [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>].</p><p><italic>Msx1 </italic>and <italic>Msx2</italic>, closely related members of the <italic>Nk</italic>-family of homeobox transcription factors, have well-documented roles as both downstream effectors and upstream regulators of Bmp signalling [<xref ref-type="bibr" rid="B26">26</xref>-<xref ref-type="bibr" rid="B29">29</xref>]. <italic>Msx1 </italic>and <italic>Msx2 </italic>function redundantly in multiple tissues and organs during vertebrate development, including the heart [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>]. We showed previously that <italic>Msx1-/-; Msx2-/- </italic>mutants exhibit malalignment defects of the developing outflow tract including double outlet right ventricle and pulmonary atresia or stenosis [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B32">32</xref>]. These defects are associated with excessive proliferation of cardiac neural crest, endothelial and myocardial cells in the mutant outflow tract between E10 and E11 [<xref ref-type="bibr" rid="B32">32</xref>].</p><p>Reduced expression of <italic>Msx1 </italic>and <italic>Msx2 </italic>was observed in the AV cushions deficient in Bmp signaling. Such cushions also displayed immature cardiac jelly, compromised AV myocardium and hypoplastic AV valves [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B33">33</xref>]. However, no valve defects have been reported in mice deficient in either <italic>Msx1 </italic>or <italic>Msx2 </italic>[<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>].</p><p>In the present study, we focused on AV cushion and valve formation in mice with combined deficiencies of <italic>Msx1 </italic>and <italic>Msx2</italic>, and compared marker gene expression in <italic>Msx1-/-; Msx2-/- </italic>double mutant AV cushions with that in <italic>Msx1-/- </italic>and <italic>Msx2-/- </italic>single mutant AV cushions. We observed hypoplastic AV cushions and deformed AV valves in <italic>Msx1-/-; Msx2-/- </italic>double mutants but not in <italic>Msx1-/- </italic>or <italic>Msx2-/- </italic>single mutants, and no discernable difference in the expression of AV cushion markers between wild-type and single mutant mice. On the other hand, there was a reduced level of NFATc1 immunostaining in the <italic>Msx1/2 </italic>double mutant AV endocardium, and decreased expression of &#x003b1;-smooth muscle actin, <italic>Notch1</italic>, <italic>Has2</italic>, <italic>Bmp2/4 </italic>and <italic>Pitx2 </italic>in the <italic>Msx1/2 </italic>double mutant AV cushion mesenchyme, indicating impaired EMT and cushion formation [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B36">36</xref>-<xref ref-type="bibr" rid="B41">41</xref>]. In addition, perturbed expression of <italic>Bmp2/4</italic>, <italic>Tbx2</italic>, <italic>Anf</italic>, <italic>Hand1 </italic>and <italic>Hand2 </italic>in the <italic>Msx1/2 </italic>null mutant AV myocardium suggests impaired myocardial patterning during chamber formation [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B42">42</xref>-<xref ref-type="bibr" rid="B49">49</xref>]. Taken together, we conclude that <italic>Msx1 </italic>and <italic>Msx2 </italic>function redundantly in regulating the expression of genes required for AV canal (AVC) morphogenesis.</p></sec><sec><title>Results</title><sec><title>Hypoplastic AV cushions and impaired endocardial signaling in Msx1-/-; Msx2-/- mutant hearts</title><p>Histological sections of hearts between E14.5 and E16.5 revealed atrial septal defect as well as deformed AV cushions and valves in <italic>Msx1-/-; Msx2-/- </italic>double mutants (<italic>n </italic>= 8), but not in <italic>Msx1-/- </italic>or <italic>Msx2-/- </italic>single mutants (<italic>n </italic>= 22), nor in <italic>Msx1-Msx2 </italic>homozygous-heterozygous compound mutants (<italic>n </italic>= 20). All eight <italic>Msx1/2 </italic>null mutants examined had hypoplastic AV cushions and shorter but thickened AV valves, indicating a failure to undergo proper valve outgrowth and remodeling (Fig. <xref ref-type="fig" rid="F1">1B, C, E</xref> and <xref ref-type="fig" rid="F1">1F</xref>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Hypoplastic AV cushions and disorganized AV valves in <italic>Msx1-/-</italic>; <italic>Msx2-/- </italic>double mutants at E15.5</bold>. Panels D-F are enlarged views of the boxes in panels A-C from histological sections of E15.5 embryonic hearts. Compared with the control (D), <italic>Msx1/2 </italic>null mutants have compromised AV cushions (indicated by white asterisks in the control and red asterisks in <italic>Msx1/2 </italic>double mutants), shorter and deformed AV valves extending from the cushions (indicated by triangle arrowheads in panels E and F), and hyperplastic AV valves extending from the AV myocardium (indicated by arrows in panels E and F), suggesting impaired valve outgrowth and remodeling following deficient EMT to form the AV cushions. The red arrow indicates atrial septal defect. IVS, interventricular septum; LA and LV, left atrium and ventricle; RA and RV, right atrium and ventricle. Scale bars: 0.5 mm in A (for A-C) and 0.2 mm in D, and F (for E, F).</p></caption><graphic xlink:href="1471-213X-8-75-1"/></fig><p>To evaluate the functional redundancy of <italic>Msx1 </italic>and <italic>Msx2 </italic>in AV cushion morphogenesis, we examined expression patterns of <italic>Msx1 </italic>and <italic>Msx2 </italic>in the AV canal (AVC) between E9.5 and E11.5, while EMT of the endocardial cushions was actively taking place [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B18">18</xref>]. At E9.5 and E10.5, <italic>Msx1 </italic>and <italic>Msx2 </italic>displayed overlapping expression in the endocardial and cushion mesenchymal cells, while <italic>Msx2 </italic>was also expressed in the AV myocardium, where no <italic>Msx1 </italic>expression was detected (Fig. <xref ref-type="fig" rid="F2">2A&#x02013;D</xref>). By E11.5, <italic>Msx1 </italic>expression extended to the lateral cushion mesenchyme adjacent to the AV myocardium as well as the membranous parts of the interatrial and interventricular septa (Fig. <xref ref-type="fig" rid="F2">2E</xref>). Our observations suggest that <italic>Msx1 </italic>and <italic>Msx2 </italic>may function redundantly during AV endocardial EMT and AV cushion morphogenesis.</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Expression of <italic>Msx1 </italic>and <italic>Msx2 </italic>in the developing AV canal</bold>. Section in situ hybridization showed that the domains of <italic>Msx1 </italic>and <italic>Msx2 </italic>expression overlap in a subpopulation of endocardial and cushion mesenchymal cells during AV cushion morphogenesis between E9.5 and E11.5 (A-F). <italic>Msx2 </italic>also displayed strong expression in the myocardium of the AV canal and right ventricle at all developmental stages examined (B, D and F). Red asterisks indicate AV cushions. endo, endocardium; FG, foregut; IAS and IVS, interatrial and interventricular septum; LA and LV, left atrium and ventricle; myo, myocardium; RA and RV, right atrium and ventricle. Scale bars: 0.1 mm in A (for A, B), 0.2 mm in C (for C, D) and E (for E, F).</p></caption><graphic xlink:href="1471-213X-8-75-2"/></fig><p>We then studied whether endocardial cell maturation and activation were perturbed in <italic>Msx1/2 </italic>double mutants. Immunostaining for NFATc1 (nuclear factor in activated T cells), which was previously shown to be upregulated in activated endothelial cells within the AVC [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B17">17</xref>], indicated that NFATc1 was present in the <italic>Msx1/2 </italic>double mutant AV endocardium at E10.5, but with a significantly lower staining intensity compared to the control AV endocardium (compare the regions pointed by red arrows in Fig. <xref ref-type="fig" rid="F3">3A</xref> and <xref ref-type="fig" rid="F3">3B</xref>). In contrast, the intensity of NFATc1 immunostaining in the OFT endocardium was comparable between controls and <italic>Msx1-/-; Msx2-/- </italic>mutants (compare the regions indicated by red asterisks in Fig. <xref ref-type="fig" rid="F3">3A</xref> and <xref ref-type="fig" rid="F3">3B</xref>). At the same developmental stage, the expression of <italic>Notch1</italic>, an essential inducer of EMT [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>], was greatly diminished in the <italic>Msx1/2 </italic>double mutant AV cushions compared with the control (compare the regions pointed by red arrows in Fig. <xref ref-type="fig" rid="F3">3C</xref> and <xref ref-type="fig" rid="F3">3D</xref>). In contrast, <italic>Notch1 </italic>expression in the <italic>Msx1/2 </italic>double mutant OFT cushions was comparable with that in the control OFT (compare the regions marked by red asterisks in Fig. <xref ref-type="fig" rid="F3">3C</xref> and <xref ref-type="fig" rid="F3">3D</xref>). On the other hand, the expression of another endocardial marker gene <italic>Twist1 </italic>in <italic>Msx1-/-; Msx2-/- </italic>double mutants was comparable with that in control embryos (data not shown).</p><p>We also analysed expression of <italic>Has2</italic>, which is the principle synthase of the extracellular matrix component hyaluronan (HA) [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B36">36</xref>], in the AV cushion mesenchyme of the <italic>Msx1-/-; Msx2-/- </italic>mutants. HA has been demonstrated to mediate endocardial cushion expansion by interacting with water and other extracellular matrix components to create a hydrated low-resistance macromolecular environment that promotes loss of cell contact inhibition and increased cell motility, which is a prerequisite of cardiac cushion expansion and subsequent EMT [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B50">50</xref>-<xref ref-type="bibr" rid="B52">52</xref>]. Our results indicated normal expression of <italic>Has2 </italic>in spite of a greatly decreased number of <italic>Has2</italic>-expressing cells in the <italic>Msx1/2 </italic>double mutant AV cushion mesenchyme (compare the regions pointed by red arrows in Fig. <xref ref-type="fig" rid="F3">3E</xref> and <xref ref-type="fig" rid="F3">3F</xref>). Statistical analyses of multiple sections across the AV cushions revealed that, in spite of normal cell proliferation and apoptosis, there was a significant reduction in the total number of mesenchymal cells in <italic>Msx1-/-; Msx2-/- </italic>mutants compared with their littermate controls (Fig. <xref ref-type="fig" rid="F4">4</xref> and data not shown). In addition, we found that there were only sparse mesenchymal cells expressing &#x003b1;-smooth muscle actin (&#x003b1;-SMA) in the <italic>Msx1/2 </italic>double mutant AV cushions, whereas the majority of mesenchymal cells in the control AV cushions are &#x003b1;-SMA-positive (compare the regions indicated by red asterisks in Fig. <xref ref-type="fig" rid="F4">4C, 4D, 4G</xref> and <xref ref-type="fig" rid="F4">4H</xref>). As &#x003b1;-SMA was previously shown to be a marker of EMT [<xref ref-type="bibr" rid="B39">39</xref>], our results further support impaired EMT in the <italic>Msx1/2 </italic>null mutant AV cushions, which may contribute to a decreased total number of cushion mesenchymal cells.</p><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Impaired expression of endocardial and cushion mesenchymal genes in <italic>Msx1-/-</italic>; <italic>Msx2-/- </italic>mutant AV cushions</bold>. At E10.5, the immunostaining intensity of NFATc1 was reduced in <italic>Msx1-/-</italic>; <italic>Msx2-/- </italic>mutant AV endocardium compared with the littermate control (red arrows in A, B), while the intensity was comparable between control and <italic>Msx1/2 </italic>double mutant OFT endocardium (red asterisks in A, B). At the same developmental stage, RNA section in situ hybridization revealed greatly diminished expression of <italic>Notch1 </italic>(arrows in C, D) in the <italic>Msx1/2 </italic>double mutant AV cushion mesenchyme and endocardium compared with the control. In contrast, <italic>Notch1 </italic>expression was normal in the <italic>Msx1/2 </italic>mutant OFT cushions (compare red asterisks in C and D). Note also a decreased number of <italic>Has2</italic>-expressing cells in the <italic>Msx1/2 </italic>null mutant AV cushion mesenchyme (red arrows in E, F). endo, endocardium; LA and LV, left atrium and ventricle; mes, mesenchyme; RA and RV, right atrium and ventricle. Scale bars: 0.1 mm in B (for A-D), 0.2 mm in F (for E, F).</p></caption><graphic xlink:href="1471-213X-8-75-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Normal proliferation but decreased total cell numbers in <italic>Msx1-/-</italic>; <italic>Msx2-/- </italic>mutant AV cushions during EMT</bold>. Immunostaining with the anti-BrdU antibody at both E11.5 and E12.5 revealed comparable levels of cell proliferation in the AV cushions and atrial and ventricular myocardium of <italic>Msx1-/-</italic>; <italic>Msx2-/- </italic>mutants and their littermate controls (compare A with B and E with F). Immunostaining against &#x003b1;-smooth muscle actin (&#x003b1;-SMA) showed dramatically reduced numbers of &#x003b1;-SMA-positive mesenchymal cells in the <italic>Msx1/2 </italic>null mutant AV cushions compared with the control (red arrows in D and H indicate sparse &#x003b1;-SMA-positive cells in the double mutant AV cushions). White asterisks in A, B, E and F, and red asterisks in C, D, G and H indicate the location of the AV cushions. I, Statistical analyses revealed significantly reduced total cell numbers in the AV cushions of the <italic>Msx1/2 </italic>double mutants compared with those of their littermate controls (at least 4 sections were counted for each embryo, and 3 pairs of <italic>Msx1/2 </italic>double mutants and their littermate controls were analysed; <italic>P </italic>&#x0003c; 0.01 for both E10.5 and E11.5, Student's <italic>t </italic>test). IVS, interventricular septum; LA and LV, left atrium and ventricle; RA and RV, right atrium and ventricle. Scale bars: 0.1 mm in A (for A, B), C (for C, D), F (for E, F) and H (for G, H).</p></caption><graphic xlink:href="1471-213X-8-75-4"/></fig></sec><sec><title>Loss of function of both Msx1 and Msx2 perturbs myocardial signaling in the AV canal</title><p>A variety of Bmps (bone morphogenetic proteins), including Bmp2, Bmp4, Bmp5, Bmp6 and Bmp7, have been implicated in regulating EMT during OFT and AV valve formation [<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B53">53</xref>,<xref ref-type="bibr" rid="B54">54</xref>]. As <italic>Msx1 </italic>and <italic>Msx2 </italic>both have been shown to be upstream regulators of <italic>Bmp2</italic>, <italic>Bmp4 </italic>and <italic>Bmp7 </italic>during organogenesis [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B55">55</xref>-<xref ref-type="bibr" rid="B57">57</xref>], we asked whether the EMT-regulating Bmp signals were deficient in <italic>Msx1/2 </italic>mutant AV cushions. Immunostaining for Bmp2/4 and phosphorylated Smad1/5/8 at E10.5 and E11.5 revealed significantly decreased Bmp2/4 signaling (more than 50% decrease at E10.5 and more than 30% decrease at E11.5) in the AV cushion mesenchyme of <italic>Msx1-/-; Msx2-/- </italic>mutants compared with their littermate controls (Fig. <xref ref-type="fig" rid="F5">5E&#x02013;H, 5M&#x02013;P, 5Q</xref> and <xref ref-type="fig" rid="F5">5R</xref>; AV cushions are marked by red and yellow asterisks). In addition to the AV cushions, we also found decreased Bmp2/4 signaling in the atrial and ventricular myocardium of <italic>Msx1/2 </italic>double mutants (indicated by white triangle arrowheads in Fig. <xref ref-type="fig" rid="F5">5A&#x02013;D</xref> and <xref ref-type="fig" rid="F5">5I&#x02013;L</xref>). Therefore, in contrast to the local upregulation of Bmp2/4 signaling in the <italic>Msx1/2 </italic>null mutant OFT and pharyngeal mesoderm (white arrows in Fig. <xref ref-type="fig" rid="F5">5A&#x02013;D</xref>, and our previous study) [<xref ref-type="bibr" rid="B32">32</xref>], down-regulation of Bmp2/4 signaling in <italic>Msx1/2 </italic>double mutants is restricted to the AV cushions and chamber myocardium.</p><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Reduced Bmp2/4 signaling in <italic>Msx1-/-</italic>; <italic>Msx2-/- </italic>mutant AV cushions and myocardium during EMT</bold>. Panels E-H and M-P are enlarged views of the boxes in panels A-D (at E10.5) and I-L (at E11.5), respectively. Immunostaining for Bmp2/4 (green fluorescence in A, B, E, F, I, J, M and N) and phosphorylated Smad1/5/8 (red fluorescence in C, D, G, H, K, L, O and P) revealed dramatically reduced Bmp2/4-positive and phospho-Smad-positive signals in the <italic>Msx1/2 </italic>mutant AV cushion mesenchyme (red asterisks in B, F, J, N and yellow asterisks in D, H, L, P) and myocardium (white triangle arrowheads in B, D, J and L) compared with the control (A, C, E, G, I, K, M and O). On the other hand, <italic>Msx1-/-</italic>; <italic>Msx2-/- </italic>mutants exhibit broader expression patterns of both Bmp2/4 and Smad1/5/8 in the pharyngeal mesoderm compared with controls (indicated by white arrows in A-D). Q and R indicate average percentages of Bmp2/4-positive and phospho-Smad1/5/8-positive cells in the control and <italic>Msx1/2 </italic>mutant AV cushions at E10.5 and E11.5 (<italic>n </italic>= 3 for each developmental stage, <italic>P </italic>&#x0003c; 0.001, Student's <italic>t </italic>test). LA and LV, left atrium and ventricle; RA and RV, right atrium and ventricle. Scale bars: 0.1 mm in A (for A-D), F (for E-H), I (for I-L) and N (for M-P).</p></caption><graphic xlink:href="1471-213X-8-75-5"/></fig><p>Previous studies have demonstrated that <italic>Bmp2 </italic>induces <italic>Tbx2 </italic>(T-box transcription factor 2) expression in the AV myocardium, which in turn inhibits the expression of chamber-specific genes including <italic>Anf </italic>(atrial natriuretic factor), <italic>Chisel </italic>and <italic>Cx40 </italic>in the AVC, and thus establishes the identity of chamber myocardium [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B49">49</xref>]. To investigate whether reduced Bmp2/4 signaling in <italic>Msx1/2 </italic>mutant AVC perturbed gene expression in the AV myocardium, we compared expression of <italic>Tbx2 </italic>and <italic>Anf </italic>in controls and <italic>Msx1/2 </italic>double mutants. In <italic>Msx1-/-; Msx2-/- </italic>mutants, <italic>Tbx2 </italic>expression was dramatically reduced in the AV myocardium (compare the regions pointed by red arrowheads in Fig. <xref ref-type="fig" rid="F6">6A</xref> and <xref ref-type="fig" rid="F6">6B</xref>). This is a local down-regulation, as <italic>Tbx2 </italic>expression in the pharyngeal mesoderm was comparable between controls and <italic>Msx1/2 </italic>double mutants (compare the regions pointed by black arrows in Fig. <xref ref-type="fig" rid="F6">6A</xref> and <xref ref-type="fig" rid="F6">6B</xref>). In agreement with decreased <italic>Tbx2 </italic>expression, <italic>Msx1/2 </italic>double mutants displayed increased and ectopic expression of <italic>Anf </italic>in the AV myocardium (compare the regions pointed by red arrowheads in Fig. <xref ref-type="fig" rid="F6">6C</xref> and <xref ref-type="fig" rid="F6">6D</xref>). <italic>Anf </italic>expression was also increased in the myocardium of the double mutant right ventricle (marked by the red asterisk in Fig. <xref ref-type="fig" rid="F6">6D</xref>).</p><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold>Perturbed expression of chamber-specific genes in <italic>Msx1-/-</italic>; <italic>Msx2-/- </italic>mutant myocardium</bold>. RNA section in situ hybridization at E10.5 demonstrated that <italic>Tbx2 </italic>expression was dramatically reduced in the <italic>Msx1/2 </italic>null mutant AV myocardium compared with the littermate control (compare the staining intensity in the regions pointed by red notched arrowheads in A and B). In contrast, the level of <italic>Tbx </italic>expression in the pharyngeal mesoderm was comparable between the control and the <italic>Msx1/2 </italic>double mutant (indicated by black arrows in A and B). Concomitant with decreased <italic>Tbx2 </italic>expression in the <italic>Msx1-/-; Msx2-/- </italic>mutant AV myocardium, <italic>Anf </italic>expression exhibited increased expression in the <italic>Msx1/2 </italic>double mutant AV myocardium (compare the staining intensity in the regions pointed by red notched arrowheads in C and D). In addition, we detected ectopic <italic>Anf </italic>expression in the double mutant right ventricle (red asterisk in D), which was likely a hemodynamic effect secondary to the changes of gene expression in the AV canal. <italic>Msx1/2 </italic>null mutants also exhibited decreased expression of <italic>Hand1 </italic>(F) and <italic>Hand2 </italic>(H) in the AV myocardium (red notched arrowheads). In the <italic>Msx1/2 </italic>mutant AV myocardium, <italic>Hand1 </italic>expression was almost undetectable and <italic>Hand2 </italic>expression was significantly reduced compared with the control (red notched arrowheads in E-H). LA and LV, left atrium and ventricle; RA and RV, right atrium and ventricle. Scale bars: 0.1 mm in A (for A-D) and E (for E-H).</p></caption><graphic xlink:href="1471-213X-8-75-6"/></fig><p>In addition to <italic>Tbx2</italic>, other transcription factors that have been implicated in regulation of <italic>Anf </italic>expression, including <italic>Hand1 </italic>[<xref ref-type="bibr" rid="B46">46</xref>], <italic>Hand2 </italic>[<xref ref-type="bibr" rid="B47">47</xref>], and <italic>Pitx2 </italic>[<xref ref-type="bibr" rid="B58">58</xref>], also exhibited dramatically reduced expression in <italic>Msx1-/-; Msx2-/- </italic>mutant AVC (Fig. <xref ref-type="fig" rid="F6">6E&#x02013;H</xref> and Fig. <xref ref-type="fig" rid="F7">7</xref>). <italic>Hand1 </italic>is normally expressed in the left AV myocardium [<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B59">59</xref>], but this was almost undetectable in <italic>Msx1/2 </italic>double mutants (compare the regions pointed by red arrows in Fig. <xref ref-type="fig" rid="F6">6E</xref> and <xref ref-type="fig" rid="F6">6F</xref>). In addition, <italic>Hand1 </italic>expression was significantly decreased in the left ventricular myocardium of the <italic>Msx1/2 </italic>null mutants compared with the controls (marked by a red asterisk in Fig. <xref ref-type="fig" rid="F6">6F</xref>; three pairs of <italic>Msx1-/-; Msx2-/- </italic>mutants and littermate controls were analysed). Similar to <italic>Hand1</italic>, there was an overall decrease of <italic>Hand2 </italic>expression in the <italic>Msx1/2 </italic>double mutant myocardium (compare Fig. <xref ref-type="fig" rid="F6">6G</xref> and <xref ref-type="fig" rid="F6">6H</xref>). In fact, we have previously demonstrated reduced <italic>Hand1 </italic>and <italic>Hand2 </italic>expression in the <italic>Msx1/2 </italic>null mutant OFT and secondary heart field, suggesting that <italic>Hand1 </italic>and <italic>Hand2 </italic>are target genes regulated by <italic>Msx1 </italic>and <italic>Msx2 </italic>[<xref ref-type="bibr" rid="B32">32</xref>]. We found that, in contrast to the control AV cushions, where approximately 40&#x02013;60% of mesenchymal cells expressed <italic>Pitx2 </italic>(Fig. <xref ref-type="fig" rid="F7">7C, 7G</xref> and <xref ref-type="fig" rid="F7">7I</xref>; AV cushions are marked by yellow asterisks), there were only sparse <italic>Pitx2</italic>-expressing mesenchymal cells (average &#x02266;10%) in the <italic>Msx1/2 </italic>double mutant AV cushions (Fig. <xref ref-type="fig" rid="F7">7D, 7H</xref> and <xref ref-type="fig" rid="F7">7I</xref>). In addition, there was a substantial reduction of Pitx2 immunostaining signal in the myocardium of the <italic>Msx1/2 </italic>double mutant left atrium shown in Fig. <xref ref-type="fig" rid="F7">7B</xref> and <xref ref-type="fig" rid="F7">7F</xref> (indicated by white arrows; compare with Fig. <xref ref-type="fig" rid="F6">6A</xref> and <xref ref-type="fig" rid="F6">6E</xref>). Multiple lines of evidence have shown that loss of <italic>Hand1 </italic>or <italic>Pitx2 </italic>expression in the AVC cause AV valve defects [<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B60">60</xref>]. Myocardium-specific deficiency of <italic>Hand1 </italic>was shown to cause hyperplastic AV cushions and thickened AV valves [<xref ref-type="bibr" rid="B45">45</xref>], implicating <italic>Hand1 </italic>in post EMT valve remodelling [<xref ref-type="bibr" rid="B6">6</xref>]. <italic>Pitx2 </italic>may be required for both EMT and post EMT cushion morphogenesis, as <italic>Pitx2 </italic>descendents were reported to be indispensable for late AV cushion formation and AV valve remodelling [<xref ref-type="bibr" rid="B38">38</xref>].</p><fig position="float" id="F7"><label>Figure 7</label><caption><p><bold>Decreased contribution of Pitx2-positive cells to the <italic>Msx1-/-</italic>; <italic>Msx2-/- </italic>mutant AV cushion mesenchyme</bold>. Panels C, D, G and H are enlarged views of the boxes in A, B (at E10.5) and E, F (at E11.5), respectively. Pitx2 immunostaining (green fluorescence) revealed a substantial reduction in the number of Pitx2-positive cells in the <italic>Msx1-/-</italic>; <italic>Msx2-/- </italic>mutant AV cushion mesenchyme compared with the control (compare the regions marked by yellow asterisks in C, D, G and H). White notched arrowheads in D and H indicate sparse Pitx2-positive mesenchymal cells in the <italic>Msx1/2 </italic>null mutant AV cushions. There was no detectable Pitx2 expression in the left atrial myocardium of the <italic>Msx1/2 </italic>double mutants shown in B and F (indicated by white arrows). I, Statistical analyses revealed significantly reduced percentages of Pitx2-positive cells in the AV cushion mesenchyme of the <italic>Msx1/2 </italic>double mutants at both E10.5 and E11.5 (<italic>n </italic>= 3 for each developmental stage, <italic>P </italic>&#x0003c; 0.01 at E10.5, <italic>P </italic>&#x0003c; 0.001 at E11.5, Student's <italic>t </italic>test). LA and LV, left atrium and ventricle; RA and RV, right atrium and ventricle. Scale bars: 0.1 mm in B (for A, B) and F (for E, F), 0.05 mm in D (for C, D) and H (for G, H).</p></caption><graphic xlink:href="1471-213X-8-75-7"/></fig></sec></sec><sec><title>Discussion</title><p>Previous studies have demonstrated that <italic>Msx1 </italic>and <italic>Msx2 </italic>are both expressed in the AV endocardium, while <italic>Msx2 </italic>is also expressed in the cushion mesenchyme and AV myocardium [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B61">61</xref>,<xref ref-type="bibr" rid="B62">62</xref>]. In this study, we demonstrated overlapping expression of <italic>Msx1 </italic>and <italic>Msx2 </italic>in not only the AV endocardium but also the cushion mesenchyme (Fig. <xref ref-type="fig" rid="F2">2</xref>). In support of the overlapping expression patterns, <italic>Msx1 </italic>and <italic>Msx2 </italic>exhibited redundant functions in the AV endocardium and cushion mesenchyme during EMT. We found that <italic>Msx1 </italic>and <italic>Msx2 </italic>function redundantly to upregulate <italic>NFATc1 </italic>expression in the AV endocardium and maintain <italic>Notch1 </italic>and <italic>Bmp2/4 </italic>expression in the AV cushions during EMT (Fig. <xref ref-type="fig" rid="F3">3A&#x02013;D</xref> and Fig. <xref ref-type="fig" rid="F5">5</xref>). Previous studies demonstrated that NFATc1 signaling during valve morphogenesis is dispensable for EMT (between E8.5 and E10.5) but is required for remodeling of the endocardial cushions into mature valve leaflets (after E11) [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B63">63</xref>]. NFATc1 was found to regulate valve remodeling by transcriptional activation of matrix degrading enzymes including cathepsin K, whose substrates are collagen and elastin, via the RANKL signaling pathway [<xref ref-type="bibr" rid="B63">63</xref>]. Notch signaling in the AV endocardium was reported to promote loss of cell-cell contact via down-regulation of endocardial <italic>VE-cadherin </italic>and induce EMT via upregulation of myocardial <italic>TGF-&#x003b2;2 </italic>[<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. To initiate EMT, Bmp2 acts synergistically with TGF-&#x003b2;s to enhance the TGF-&#x003b2;-induced phenotypic changes associated with EMT [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B40">40</xref>].</p><p>We failed to detect any significant change of expression of <italic>Twist1</italic>, which has been implicated in down-regulation of <italic>E-cadherin </italic>and <italic>VE-cadherin </italic>during epithelial- or endothelial-to-mesenchymal transition [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B64">64</xref>,<xref ref-type="bibr" rid="B65">65</xref>]. It is likely that the expression levels of other transcription factors which also repress <italic>E-cadherin</italic>/<italic>VE-cadherin </italic>expression, including <italic>Snail </italic>and <italic>Slug </italic>[<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B64">64</xref>], are decreased in the <italic>Msx1-/-; Msx2-/- </italic>mutant AV endocardium. In fact, <italic>Snail </italic>expression is activated by Notch signaling [<xref ref-type="bibr" rid="B22">22</xref>]. It remains to be determined whether the expression of <italic>Snail </italic>and <italic>VE-cadherin </italic>are perturbed in the <italic>Msx1/2 </italic>double mutant AV endocardium.</p><p>In agreement with impaired EMT, we observed significantly decreased total numbers of mesenchymal cells in the <italic>Msx1-/-; Msx2-/- </italic>mutant AV cushions (Fig. <xref ref-type="fig" rid="F4">4I</xref>). Furthermore, only a small proportion of mesenchymal cells in the <italic>Msx1/2 </italic>double mutant AV cushions expressed &#x003b1;-SMA, suggesting impaired differentiation during EMT (Fig. <xref ref-type="fig" rid="F4">4D</xref> and <xref ref-type="fig" rid="F4">4H</xref>). On the other hand, both cell proliferation and cell survival were normal in <italic>Msx1-/-; Msx2-/- </italic>mutant AV cushions during EMT (Fig. <xref ref-type="fig" rid="F4">4A, B, E, F</xref> and data not shown).</p><p>Interestingly, we found decreased Bmp2/4 signaling and expression of <italic>Tbx2</italic>, <italic>Hand1 </italic>and <italic>Hand2 </italic>in the <italic>Msx1-/-; Msx2-/- </italic>mutant myocardium, including the AV myocardium, which expresses <italic>Msx2 </italic>but not <italic>Msx1 </italic>in wild-type embryos, and the chamber myocardium, where neither <italic>Msx1 </italic>nor <italic>Msx2 </italic>is normally expressed. One possible explanation is that perturbed gene expression in the double mutant myocardium is a secondary effect of hemodynamic changes due to the absence of normal AV cushions. Reduced expression of both <italic>Hand1 </italic>and <italic>Hand2 </italic>in the <italic>Msx1/2 </italic>null mutant myocardium further supports our previous hypothesis that <italic>Hand1 </italic>and <italic>Hand2 </italic>are candidate target genes regulated by <italic>Msx1 </italic>and <italic>Msx2 </italic>[<xref ref-type="bibr" rid="B32">32</xref>]. Decreased <italic>Hand1 </italic>expression in the <italic>Msx1/2 </italic>double mutant AV myocardium may be associated with defects in remodeling of the AV cushions into mature valve leaflets, since myocardium-specific <italic>Hand1 </italic>deficiency led to thickened AV valves [<xref ref-type="bibr" rid="B45">45</xref>], which were previously shown to be associated with impaired valve remodeling [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B15">15</xref>].</p><p>It is noteworthy that, in contrary to decreased Bmp2/4 signaling in the <italic>Msx1/2 </italic>null mutant AVC and chamber myocardium, our previous study demonstrated increased Bmp2/4 signaling in the double mutant OFT myocardium and cushion mesenchyme [<xref ref-type="bibr" rid="B32">32</xref>]. It has been shown that <italic>Bmp2 </italic>expression is normally switched from the OFT myocardium to the AVC and atrial myocardium between E9.5 and E10.5 [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B61">61</xref>,<xref ref-type="bibr" rid="B66">66</xref>], suggesting that an alternative explanation for perturbed Bmp signaling in <italic>Msx1-/-; Msx2-/- </italic>mutant hearts is that <italic>Bmp2 </italic>expression does not shift from the OFT to the AVC in the double mutants. Locally reduced <italic>Bmp2 </italic>expression in the <italic>Msx1/2 </italic>null mutant AVC may be insufficient to maintain normal expression of <italic>Tbx2 </italic>and in turn lead to reduced <italic>Tbx2 </italic>and increased <italic>Anf </italic>expression in the double mutant AV myocardium (Fig. <xref ref-type="fig" rid="F6">6A&#x02013;D</xref>) [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B49">49</xref>]. Perturbed <italic>Bmp2 </italic>expression may also disrupt normal <italic>Pitx2 </italic>expression in the <italic>Msx1-/-; Msx2-/- </italic>mutant AVC and atrial myocardium, as <italic>Bmp2 </italic>has been shown to be a positive regulator of <italic>Nodal </italic>signaling and <italic>Pitx2 </italic>[<xref ref-type="bibr" rid="B67">67</xref>]. In addition, there may be altered expression patterns of other Bmp molecules, including <italic>Bmp6</italic>, that contribute to the abnormal distribution of Bmp signals in the <italic>Msx1-/-; Msx2-/- </italic>mutant OFT and AV cushions. Interestingly, <italic>Bmp6 </italic>exhibits an asymmetric (left-sided) expression in the OFT myocardium at E10.5, reminiscent of the expression pattern of <italic>Pitx2 </italic>[<xref ref-type="bibr" rid="B53">53</xref>]. <italic>Bmp6 </italic>expression undergoes a transition from the AV cushion mesenchyme to the OFT cushion mesenchyme between E10.5 and E12.5, indicating that it plays a critical role in both the EMT of the AV cushions and the development of the OFT cushions [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B53">53</xref>]. Further analyses of the expression patterns of the aforementioned Bmp ligands will determine which Bmp molecules are critical contributors to the impaired development of the <italic>Msx1-/-; Msx2-/- </italic>mutant OFT and AV cushions.</p></sec><sec><title>Conclusion</title><p>In this study, we documented redundant functions of <italic>Msx1 </italic>and <italic>Msx2 </italic>genes in distinct aspects during AV cushion morphogenesis: endocardial activation prior to EMT (via upregulation of <italic>NFATc1 </italic>expression), induction of EMT (via upregulation of Notch1 and Bmp2/4 signaling in the AVC), as well as post-EMT valve remodelling (via upregulation of <italic>Hand1 </italic>expression in the AV myocardium).</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Mouse strains and genotyping</title><p>All mice used in this study were maintained in a mixed genetic background of BALB/c and CD-1. <italic>Msx1-/- </italic>and <italic>Msx2-/- </italic>single knockout and <italic>Msx1-/-; Msx2-/- </italic>double knockout mice were described previously [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. The noon copulation plug was counted as embryonic day 0.5 (E0.5). Genomic DNA was extracted from yolk sac (embryos) or tails (postnatal mice) for genotyping. PCR primers and conditions for <italic>Msx1 </italic>and <italic>Msx2 </italic>knockout alleles as well as the <italic>Wnt1-Cre </italic>and <italic>R26R </italic>transgenes were as described [<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B68">68</xref>].</p></sec><sec><title>Histology, section in situ hybridization and immunostaining</title><p>For histology, embryos at E15.5 were fixed with 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS) for 14 hours at 4&#x000b0;C, dehydrated through graded ethanol and embedded in paraffin wax. Sections were cut at 7&#x02013;8 &#x003bc;m and stained with Hematoxylin and Eosin. For cryostat sectioning, fixed embryos at E10.5 were dehydrated through graded methanol and stored in 100% methanol at -20&#x000b0;C till use. Stored embryos were rehydrated through graded methanol, washed in PBS, and cryopreserved in sucrose solutions with increasing concentrations, then frozen in O.C.T Sections were cut at 10-&#x003bc;m thickness and RNA section in situ hybridization was performed using the In Situ Hybridization kit (BioChain) with the protocol modified according to Dijkman et al. [<xref ref-type="bibr" rid="B69">69</xref>]. All RNA probes were generated as described: <italic>Anf </italic>[<xref ref-type="bibr" rid="B17">17</xref>], <italic>Hand1 </italic>[<xref ref-type="bibr" rid="B45">45</xref>], <italic>Hand2 </italic>[<xref ref-type="bibr" rid="B45">45</xref>], <italic>Has2 </italic>[<xref ref-type="bibr" rid="B17">17</xref>], <italic>Notch1 </italic>[<xref ref-type="bibr" rid="B17">17</xref>], <italic>Pitx2 </italic>[<xref ref-type="bibr" rid="B38">38</xref>], and <italic>Tbx2 </italic>[<xref ref-type="bibr" rid="B17">17</xref>].</p><p>For immunostaining, the following primary antibodies were used: biotinylated goat polyclonal anti-BMP-2/4 (1:100, R&#x00026;D Systems), mouse monoclonal anti-bromodeoxyuridine (BrdU) (1:100, Sigma), mouse monoclonal anti-NFATc1 (1:200, BD Pharmingen; a kind gift from Dr. Kaartinen), guinea pig polyclonal anti-Pitx2 (1:200, a kind gift from Dr. Kioussi [<xref ref-type="bibr" rid="B70">70</xref>]), rabbit polyclonal anti-phospho-Smad1/5/8 (1:50, Cell Signaling).</p><p>Littermates of each <italic>Msx1-/-; Msx2-/- </italic>mutant embryo were used as the controls, and no discernable variation in either gene expression or cell proliferation/survival/differentiation was detected between the controls from the same litter and with different genotypes.</p></sec></sec><sec><title>Abbreviations</title><p>Anf: Atrial natriuretic factor; AV: Atrioventricular; Bmp: Bone morphogenetic protein; EMT: Endothelial-mesenchymal transformation; NFAT: Nuclear factor in activated T cells; PBS: Phosphate-buffered saline; PFA: Paraformaldehyde; TGF: Transforming growth factor.</p></sec><sec><title>Authors' contributions</title><p>Y&#x02013;HC designed most of the experiments, carried out mouse dissections at E10.5 and E11.5, analyzed the results and drafted the manuscript. MI performed mouse dissections and histological analyses at E15.5, and first observed the phenotype of malformed AV valves in <italic>Msx1-/-; Msx2-/- </italic>double mutants. HMS diagnosed the AV cushion and valve defects in <italic>Msx1/2 </italic>double mutant mice. REM conceived, funded and supervised the project, which was carried out in his laboratory. Both HMS and REM critically read and revised the manuscript. All authors have read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We are grateful to Dr. Chrissa Kioussi for the kind gift of anti-Pitx2 antibody, Dr. Vesa Kaartinen for the kind gift of anti-NFATc1 antibody, and Drs. James F. Martin and Eric N. Olson for the cRNA probes. This work was supported by NIH grants DE12941 and DE12450 to RM.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schroeder</surname><given-names>JA</given-names></name><name><surname>Jackson</surname><given-names>LF</given-names></name><name><surname>Lee</surname><given-names>DC</given-names></name><name><surname>Camenisch</surname><given-names>TD</given-names></name></person-group><article-title>Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling</article-title><source>J Mol Med</source><year>2003</year><volume>81</volume><fpage>392</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">12827270</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>D</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name></person-group><article-title>A genetic blueprint for cardiac development</article-title><source>Nature</source><year>2000</year><volume>407</volume><fpage>221</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">11001064</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zaffran</surname><given-names>S</given-names></name><name><surname>Frasch</surname><given-names>M</given-names></name></person-group><article-title>Early signals in cardiac development</article-title><source>Circ Res</source><year>2002</year><volume>91</volume><fpage>457</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">12242263</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname><given-names>EJ</given-names></name><name><surname>Bischoff</surname><given-names>J</given-names></name></person-group><article-title>Heart valve development. Endothelial cell signaling and differentiation</article-title><source>Circ Res</source><year>2004</year><volume>95</volume><fpage>459</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">15345668</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eisenberg</surname><given-names>LM</given-names></name><name><surname>Markwald</surname><given-names>RR</given-names></name></person-group><article-title>Molecular regulation of atrioventricular valvuloseptal morphogenesis</article-title><source>Circ Res</source><year>1995</year><volume>77</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">7788867</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iwamoto</surname><given-names>R</given-names></name><name><surname>Mekada</surname><given-names>E</given-names></name></person-group><article-title>ErbB and HB-EGF signaling in heart development and function</article-title><source>Cell Struct Funct</source><year>2006</year><volume>31</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">16508205</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Lange</surname><given-names>FJ</given-names></name><name><surname>Moorman</surname><given-names>AFM</given-names></name><name><surname>Anderson</surname><given-names>RH</given-names></name><name><surname>M&#x000e4;nner</surname><given-names>J</given-names></name><name><surname>Soufan</surname><given-names>AT</given-names></name><name><surname>de Gier-de Vries</surname><given-names>C</given-names></name><name><surname>Schneider</surname><given-names>MD</given-names></name><name><surname>Webb</surname><given-names>S</given-names></name><name><surname>van den Hoff</surname><given-names>MJB</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name></person-group><article-title>Lineage and morphogenetic analysis of the cardiac valves</article-title><source>Circ Res</source><year>2004</year><volume>95</volume><fpage>645</fpage><lpage>654</lpage><pub-id pub-id-type="pmid">15297379</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lakkis</surname><given-names>MM</given-names></name><name><surname>Epstein</surname><given-names>JA</given-names></name></person-group><article-title>Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart</article-title><source>Development</source><year>1998</year><volume>125</volume><fpage>4359</fpage><lpage>4367</lpage><pub-id pub-id-type="pmid">9778496</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CP</given-names></name><name><surname>Neilson</surname><given-names>JR</given-names></name><name><surname>Bayle</surname><given-names>JH</given-names></name><name><surname>Gestwicki</surname><given-names>JE</given-names></name><name><surname>Kuo</surname><given-names>A</given-names></name><name><surname>Stankunas</surname><given-names>K</given-names></name><name><surname>Graef</surname><given-names>IA</given-names></name><name><surname>Crabtree</surname><given-names>GR</given-names></name></person-group><article-title>A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis</article-title><source>Cell</source><year>2004</year><volume>118</volume><fpage>649</fpage><lpage>663</lpage><pub-id pub-id-type="pmid">15339668</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de la Pompa</surname><given-names>JL</given-names></name><name><surname>Timmerman</surname><given-names>LA</given-names></name><name><surname>Takimoto</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Elia</surname><given-names>AJ</given-names></name><name><surname>Samper</surname><given-names>E</given-names></name><name><surname>Potter</surname><given-names>J</given-names></name><name><surname>Wakeham</surname><given-names>A</given-names></name><name><surname>Marengere</surname><given-names>L</given-names></name><name><surname>Langille</surname><given-names>BL</given-names></name><name><surname>Crabtree</surname><given-names>GR</given-names></name><name><surname>Mak</surname><given-names>TW</given-names></name></person-group><article-title>Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum</article-title><source>Nature</source><year>1998</year><volume>392</volume><fpage>182</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">9515963</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>EN</given-names></name><name><surname>Lee</surname><given-names>YM</given-names></name><name><surname>Sander</surname><given-names>TL</given-names></name><name><surname>Rabkin</surname><given-names>E</given-names></name><name><surname>Schoen</surname><given-names>FJ</given-names></name><name><surname>Kaushal</surname><given-names>S</given-names></name><name><surname>Bischoff</surname><given-names>J</given-names></name></person-group><article-title>NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>1686</fpage><lpage>1692</lpage><pub-id pub-id-type="pmid">12427739</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ranger</surname><given-names>AM</given-names></name><name><surname>Grusby</surname><given-names>MJ</given-names></name><name><surname>Hodge</surname><given-names>MR</given-names></name><name><surname>Gravallese</surname><given-names>EM</given-names></name><name><surname>de la Brousse</surname><given-names>FC</given-names></name><name><surname>Hoey</surname><given-names>T</given-names></name><name><surname>Mickanin</surname><given-names>C</given-names></name><name><surname>Baldwin</surname><given-names>HS</given-names></name><name><surname>Glimcher</surname><given-names>LH</given-names></name></person-group><article-title>The transcription factor NF-ATc is essential for cardiac valve formation</article-title><source>Nature</source><year>1998</year><volume>392</volume><fpage>186</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">9515964</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dor</surname><given-names>Y</given-names></name><name><surname>Camenisch</surname><given-names>TD</given-names></name><name><surname>Itin</surname><given-names>A</given-names></name><name><surname>Fishman</surname><given-names>GI</given-names></name><name><surname>McDonald</surname><given-names>JA</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name><name><surname>E.</surname><given-names>K</given-names></name></person-group><article-title>A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects</article-title><source>Development</source><year>2001</year><volume>128</volume><fpage>1531</fpage><lpage>1538</lpage><pub-id pub-id-type="pmid">11290292</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iwamoto</surname><given-names>R</given-names></name><name><surname>Yamazaki</surname><given-names>S</given-names></name><name><surname>Asakura</surname><given-names>M</given-names></name></person-group><article-title>Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart formation</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>3221</fpage><lpage>3226</lpage><pub-id pub-id-type="pmid">12621152</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>LF</given-names></name><name><surname>Qiu</surname><given-names>TH</given-names></name><name><surname>Sunnarborg</surname><given-names>SW</given-names></name><name><surname>Chang</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Patterson</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>DC</given-names></name></person-group><article-title>Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling</article-title><source>EMBO J</source><year>2003</year><volume>22</volume><fpage>2704</fpage><lpage>2716</lpage><pub-id pub-id-type="pmid">12773386</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>D&#x000e9;lot</surname><given-names>EC</given-names></name></person-group><article-title>Control of endocardial cushion and cardiac valve maturation by BMP signaling pathways</article-title><source>Mol Genet Metab</source><year>2003</year><volume>80</volume><fpage>27</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">14567955</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>MF</given-names></name><name><surname>Schwartz</surname><given-names>RJ</given-names></name><name><surname>Martin</surname><given-names>JF</given-names></name></person-group><article-title>Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning</article-title><source>Development</source><year>2005</year><volume>132</volume><fpage>5601</fpage><lpage>5611</lpage><pub-id pub-id-type="pmid">16314491</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname><given-names>Y</given-names></name><name><surname>Yamagishi</surname><given-names>T</given-names></name><name><surname>Hokari</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name></person-group><article-title>Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-b and bone morphogenetic protein (BMP)</article-title><source>Anat Rec</source><year>2000</year><volume>258</volume><fpage>119</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">10645959</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamagishi</surname><given-names>T</given-names></name><name><surname>Nakajima</surname><given-names>Y</given-names></name><name><surname>Miyazono</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name></person-group><article-title>Bone morphogenetic protein-2 acts synergistically with transforming growth factor-b3 during endothelial-mesenchymal transformation in the developing chick heart</article-title><source>J Cell Physiol</source><year>1999</year><volume>180</volume><fpage>35</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">10362015</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>V</given-names></name><name><surname>Muth</surname><given-names>AN</given-names></name><name><surname>Ransom</surname><given-names>JF</given-names></name><name><surname>Schluterman</surname><given-names>MK</given-names></name><name><surname>Barnes</surname><given-names>R</given-names></name><name><surname>King</surname><given-names>IN</given-names></name><name><surname>Grossfeld</surname><given-names>PD</given-names></name><name><surname>Srivastava</surname><given-names>D</given-names></name></person-group><article-title>Mutations in NOTCH1 cause aortic valve disease</article-title><source>Nature</source><year>2005</year><volume>437</volume><fpage>270</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">16025100</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noseda</surname><given-names>M</given-names></name><name><surname>McLean</surname><given-names>G</given-names></name><name><surname>Niessen</surname><given-names>K</given-names></name><name><surname>Chang</surname><given-names>L</given-names></name><name><surname>Pollet</surname><given-names>I</given-names></name><name><surname>Montpetit</surname><given-names>R</given-names></name><name><surname>Shahidi</surname><given-names>R</given-names></name><name><surname>Dorovini-Zis</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Beckstead</surname><given-names>B</given-names></name><name><surname>Durand</surname><given-names>RE</given-names></name><name><surname>Hoodless</surname><given-names>PA</given-names></name><name><surname>Karsan</surname><given-names>A</given-names></name></person-group><article-title>Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation</article-title><source>Circ Res</source><year>2004</year><volume>94</volume><fpage>910</fpage><lpage>917</lpage><pub-id pub-id-type="pmid">14988227</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Timmerman</surname><given-names>LA</given-names></name><name><surname>Grego-Bessa</surname><given-names>J</given-names></name><name><surname>Raya</surname><given-names>A</given-names></name><name><surname>Bertran</surname><given-names>E</given-names></name><name><surname>Perez-Pomares</surname><given-names>JM</given-names></name><name><surname>Diez</surname><given-names>J</given-names></name><name><surname>Aranda</surname><given-names>S</given-names></name><name><surname>Palomo</surname><given-names>S</given-names></name><name><surname>McCormick</surname><given-names>F</given-names></name><name><surname>Izpisua-Belmonte</surname><given-names>JC</given-names></name><name><surname>Yamagishi</surname><given-names>H</given-names></name></person-group><article-title>Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation</article-title><source>Genes Dev</source><year>2004</year><volume>18</volume><fpage>99</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">14701881</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Camenisch</surname><given-names>TD</given-names></name><name><surname>Schroeder</surname><given-names>JA</given-names></name><name><surname>Bradley</surname><given-names>J</given-names></name><name><surname>Klewer</surname><given-names>SE</given-names></name><name><surname>McDonald</surname><given-names>JA</given-names></name></person-group><article-title>Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors</article-title><source>Nat Med</source><year>2002</year><volume>8</volume><fpage>850</fpage><lpage>855</lpage><pub-id pub-id-type="pmid">12134143</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hurlstone</surname><given-names>AF</given-names></name><name><surname>Haramis</surname><given-names>AP</given-names></name><name><surname>Wienholds</surname><given-names>E</given-names></name><name><surname>Begthel</surname><given-names>H</given-names></name><name><surname>Korving</surname><given-names>J</given-names></name><name><surname>Van Eeden</surname><given-names>F</given-names></name><name><surname>Cuppen</surname><given-names>E</given-names></name><name><surname>Zivkovic</surname><given-names>D</given-names></name><name><surname>Plasterk</surname><given-names>RH</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><article-title>The Wnt/b-catenin pathway regulates cardiac valve formation</article-title><source>Nature</source><year>2003</year><volume>425</volume><fpage>633</fpage><lpage>637</lpage><pub-id pub-id-type="pmid">14534590</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liebner</surname><given-names>S</given-names></name><name><surname>Cattelino</surname><given-names>A</given-names></name><name><surname>Gallini</surname><given-names>R</given-names></name><name><surname>Rudini</surname><given-names>N</given-names></name><name><surname>Iurlaro</surname><given-names>M</given-names></name><name><surname>Piccolo</surname><given-names>S</given-names></name><name><surname>Dejana</surname><given-names>E</given-names></name></person-group><article-title>b-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse</article-title><source>J Cell Biol</source><year>2004</year><volume>166</volume><fpage>359</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">15289495</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bei</surname><given-names>M</given-names></name><name><surname>Maas</surname><given-names>R</given-names></name></person-group><article-title>FGFs and BMP4 induce both Msx1-independent and Msx1-dependent signaling pathways in early tooth development</article-title><source>Development</source><year>1998</year><volume>125</volume><fpage>4325</fpage><lpage>4333</lpage><pub-id pub-id-type="pmid">9753686</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brugger</surname><given-names>SM</given-names></name><name><surname>Merrill</surname><given-names>AE</given-names></name><name><surname>Torres-Vazquez</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>N</given-names></name><name><surname>Ting</surname><given-names>MC</given-names></name><name><surname>Cho</surname><given-names>JYM</given-names></name><name><surname>Dobias</surname><given-names>SL</given-names></name><name><surname>Yi</surname><given-names>SE</given-names></name><name><surname>Lyons</surname><given-names>K</given-names></name><name><surname>Bell</surname><given-names>JR</given-names></name><name><surname>Arora</surname><given-names>K</given-names></name><name><surname>Warrior</surname><given-names>R</given-names></name><name><surname>Maxson</surname><given-names>R</given-names></name></person-group><article-title>A phylogenetically conserved cis-regulatory module in the Msx2 promoter is sufficient for BMP-dependent transcription in murine and Drosophila embryos</article-title><source>Development</source><year>2004</year><volume>131</volume><fpage>5153</fpage><lpage>5165</lpage><pub-id pub-id-type="pmid">15459107</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hussein</surname><given-names>SM</given-names></name><name><surname>Duff</surname><given-names>EK</given-names></name><name><surname>Sirard</surname><given-names>C</given-names></name></person-group><article-title>Smad4 and b-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>48805</fpage><lpage>48814</lpage><pub-id pub-id-type="pmid">14551209</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Willert</surname><given-names>J</given-names></name><name><surname>Epping</surname><given-names>M</given-names></name><name><surname>Polack</surname><given-names>JR</given-names></name><name><surname>Brown</surname><given-names>PO</given-names></name><name><surname>Nusse</surname><given-names>RA</given-names></name></person-group><article-title>A transcriptional response to Wnt protein in human embryonic carcinoma cells</article-title><source>BMC Dev Biol</source><year>2002</year><volume>2</volume><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">12095419</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>M</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Yen</surname><given-names>HY</given-names></name><name><surname>Sucov</surname><given-names>HM</given-names></name><name><surname>Chai</surname><given-names>Y</given-names></name><name><surname>Maxson</surname><given-names>RE</given-names><suffix>Jr.</suffix></name></person-group><article-title>Combined deficiencies of Msx1 and Msx2 cause impaired patterning and survival of the cranial neural crest</article-title><source>Development</source><year>2005</year><volume>132</volume><fpage>4937</fpage><lpage>4950</lpage><pub-id pub-id-type="pmid">16221730</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maxson</surname><given-names>R</given-names></name><name><surname>Ishii</surname><given-names>M</given-names></name><name><surname>Merrill</surname><given-names>A</given-names></name></person-group><article-title>Msx genes in organogenesis and human disease</article-title><source>Adv Dev Biol Biochem</source><year>2003</year><volume>13</volume><fpage>43</fpage><lpage>68</lpage></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Ishii</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Sucov</surname><given-names>HM</given-names></name><name><surname>Maxson</surname><given-names>RE</given-names><suffix>Jr.</suffix></name></person-group><article-title>Msx1 and Msx2 regulate survival of secondary heart field precursors and post-migratory proliferation of cardiac neural crest in the outflow tract</article-title><source>Dev Biol</source><year>2007</year><volume>308</volume><fpage>421</fpage><lpage>437</lpage><pub-id pub-id-type="pmid">17601530</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Sridurongrit</surname><given-names>S</given-names></name><name><surname>Dudas</surname><given-names>M</given-names></name><name><surname>Thomas</surname><given-names>P</given-names></name><name><surname>Nagy</surname><given-names>A</given-names></name><name><surname>Schneider</surname><given-names>MD</given-names></name><name><surname>Epstein</surname><given-names>JA</given-names></name><name><surname>Kaartinen</surname><given-names>V</given-names></name></person-group><article-title>Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart</article-title><source>Dev Biol</source><year>2005</year><volume>286</volume><fpage>299</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">16140292</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Satokata</surname><given-names>I</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Ohshima</surname><given-names>H</given-names></name><name><surname>Bei</surname><given-names>M</given-names></name><name><surname>Woo</surname><given-names>I</given-names></name><name><surname>Nishizawa</surname><given-names>K</given-names></name><name><surname>Maeda</surname><given-names>T</given-names></name><name><surname>Takano</surname><given-names>Y</given-names></name><name><surname>Uchiyama</surname><given-names>M</given-names></name><name><surname>Heaney</surname><given-names>S</given-names></name><name><surname>Peters</surname><given-names>H</given-names></name><name><surname>Tang</surname><given-names>Z</given-names></name><name><surname>Maxson</surname><given-names>R</given-names></name><name><surname>Maas</surname><given-names>R</given-names></name></person-group><article-title>Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation</article-title><source>Nat Genet</source><year>2000</year><volume>24</volume><fpage>391</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">10742104</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Satokata</surname><given-names>I</given-names></name><name><surname>Maas</surname><given-names>R</given-names></name></person-group><article-title>Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development</article-title><source>Nat Genet</source><year>1994</year><volume>6</volume><fpage>348</fpage><lpage>355</lpage><pub-id pub-id-type="pmid">7914451</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Camenisch</surname><given-names>TD</given-names></name><name><surname>Spicer</surname><given-names>AP</given-names></name><name><surname>Brehm-Gibson</surname><given-names>T</given-names></name><name><surname>Biesterfeldt</surname><given-names>J</given-names></name><name><surname>Augustine</surname><given-names>ML</given-names></name><name><surname>Calabro</surname><given-names>A</given-names><suffix>Jr.</suffix></name><name><surname>Kubalak</surname><given-names>S</given-names></name><name><surname>Klewer</surname><given-names>SE</given-names></name><name><surname>McDonald</surname><given-names>JA</given-names></name></person-group><article-title>Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme</article-title><source>J Clin Invest</source><year>2000</year><volume>106</volume><fpage>349</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">10930438</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gage</surname><given-names>PJ</given-names></name><name><surname>Suh</surname><given-names>H</given-names></name><name><surname>Camper</surname><given-names>SA</given-names></name></person-group><article-title>Dosage requirement of Pitx2 for development of multiple organs</article-title><source>Development</source><year>1999</year><volume>126</volume><fpage>4643</fpage><lpage>4651</lpage><pub-id pub-id-type="pmid">10498698</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Palie</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>MF</given-names></name><name><surname>Brown</surname><given-names>NA</given-names></name><name><surname>Martin</surname><given-names>JF</given-names></name></person-group><article-title>Pitx2c patterns anterior myocardium and aortic arch vessels and is required for local cell movement into atrioventricular cushions</article-title><source>Development</source><year>2002</year><volume>129</volume><fpage>5081</fpage><lpage>5091</lpage><pub-id pub-id-type="pmid">12397115</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname><given-names>Y</given-names></name><name><surname>Mironov</surname><given-names>V</given-names></name><name><surname>Yamagishi</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Markwald</surname><given-names>RR</given-names></name></person-group><article-title>Expression of smooth muscle alpha-actin in mesenchymal cells during formation of avian endocardial cushion tissue: a role for transforming growth factor b3</article-title><source>Dev Dyn</source><year>1997</year><volume>209</volume><fpage>296</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">9215644</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Feliciano</surname><given-names>J</given-names></name><name><surname>Tabin</surname><given-names>CJ</given-names></name></person-group><article-title>Bmp2 instructs cardiac progenitors to form the heart-valve-inducing field</article-title><source>Dev Biol</source><year>2006</year><volume>295</volume><fpage>580</fpage><lpage>588</lpage><pub-id pub-id-type="pmid">16730346</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sugi</surname><given-names>Y</given-names></name><name><surname>Yamamura</surname><given-names>H</given-names></name><name><surname>Okagawa</surname><given-names>H</given-names></name><name><surname>Markwald</surname><given-names>RR</given-names></name></person-group><article-title>Bone morphogenetic protein-2 can mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice</article-title><source>Dev Biol</source><year>2004</year><volume>269</volume><fpage>505</fpage><lpage>518</lpage><pub-id pub-id-type="pmid">15110716</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christoffels</surname><given-names>VM</given-names></name><name><surname>Habets</surname><given-names>PEMH</given-names></name><name><surname>Franco</surname><given-names>D</given-names></name><name><surname>Campione</surname><given-names>M</given-names></name><name><surname>de Jong</surname><given-names>F</given-names></name><name><surname>Lamers</surname><given-names>WH</given-names></name><name><surname>Bao</surname><given-names>ZZ</given-names></name><name><surname>Palmer</surname><given-names>S</given-names></name><name><surname>Biben</surname><given-names>C</given-names></name><name><surname>Harvey</surname><given-names>RP</given-names></name><name><surname>Moorman</surname><given-names>AFM</given-names></name></person-group><article-title>Chamber formation and morphogenesis in the developing mammalian heart</article-title><source>Dev Biol</source><year>2000</year><volume>223</volume><fpage>266</fpage><lpage>278</lpage><pub-id pub-id-type="pmid">10882515</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Habets</surname><given-names>PEMH</given-names></name><name><surname>Moorman</surname><given-names>AFM</given-names></name><name><surname>Clout</surname><given-names>DEW</given-names></name><name><surname>van Roon</surname><given-names>MA</given-names></name><name><surname>Lingbeek</surname><given-names>M</given-names></name><name><surname>van Lohuizen</surname><given-names>M</given-names></name><name><surname>Campione</surname><given-names>M</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name></person-group><article-title>Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation</article-title><source>Genes Dev</source><year>2002</year><volume>16</volume><fpage>1234</fpage><lpage>1246</lpage><pub-id pub-id-type="pmid">12023302</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harrelson</surname><given-names>Z</given-names></name><name><surname>Kelly</surname><given-names>RG</given-names></name><name><surname>Goldin</surname><given-names>SN</given-names></name><name><surname>Gibson-Brown</surname><given-names>JJ</given-names></name><name><surname>Bollag</surname><given-names>RJ</given-names></name><name><surname>Silver</surname><given-names>LM</given-names></name><name><surname>Papaioannou</surname><given-names>VE</given-names></name></person-group><article-title>Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development</article-title><source>Development</source><year>2004</year><volume>131</volume><fpage>5041</fpage><lpage>5052</lpage><pub-id pub-id-type="pmid">15459098</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McFadden</surname><given-names>DG</given-names></name><name><surname>Barbosa</surname><given-names>AC</given-names></name><name><surname>Richardson</surname><given-names>JA</given-names></name><name><surname>Schneider</surname><given-names>MD</given-names></name><name><surname>Srivastava</surname><given-names>D</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name></person-group><article-title>The Hand1 and Hand2 transcription factors regulate expansion of the embryonic cardiac ventricles in a gene dosage-dependent manner</article-title><source>Development</source><year>2005</year><volume>132</volume><fpage>189</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">15576406</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morin</surname><given-names>S</given-names></name><name><surname>Pozzulo</surname><given-names>G</given-names></name><name><surname>Robitaille</surname><given-names>L</given-names></name><name><surname>Cross</surname><given-names>J</given-names></name><name><surname>Nemer</surname><given-names>M</given-names></name></person-group><article-title>MEF2-dependent recruitment of the HAND1 transcription factor results in synergistic activation of target promoters</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>32272</fpage><lpage>32278</lpage><pub-id pub-id-type="pmid">16043483</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thattaliyath</surname><given-names>BD</given-names></name><name><surname>Firulli</surname><given-names>BA</given-names></name><name><surname>Firulli</surname><given-names>AB</given-names></name></person-group><article-title>The basic-helix-loop-helix transcription factor HAND2 directly regulates transcription of the Atrial Naturetic Peptide gene</article-title><source>J Mol Cell Cardiol</source><year>2002</year><volume>34</volume><fpage>1335</fpage><lpage>1344</lpage><pub-id pub-id-type="pmid">12392994</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Togi</surname><given-names>K</given-names></name><name><surname>Kawamoto</surname><given-names>T</given-names></name><name><surname>Yamauchi</surname><given-names>R</given-names></name><name><surname>Yoshida</surname><given-names>Y</given-names></name><name><surname>Kita</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name></person-group><article-title>Role of Hand1/eHand in the dorso-ventral patterning and interventricular septum formation in the embryonic heart</article-title><source>Mol Cell Biol</source><year>2004</year><volume>24</volume><fpage>4627</fpage><lpage>4635</lpage><pub-id pub-id-type="pmid">15143159</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Revelli</surname><given-names>JP</given-names></name><name><surname>Eichele</surname><given-names>G</given-names></name><name><surname>Barron</surname><given-names>M</given-names></name><name><surname>Schwartz</surname><given-names>RJ</given-names></name></person-group><article-title>Expression of chick Tbx-2, Tbx-3, and Tbx-5 genes during early heart development: evidence for BMP2 induction of Tbx2</article-title><source>Dev Biol</source><year>2000</year><volume>228</volume><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">11087629</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collis</surname><given-names>L</given-names></name><name><surname>Hall</surname><given-names>C</given-names></name><name><surname>Lange</surname><given-names>L</given-names></name><name><surname>Ziebell</surname><given-names>M</given-names></name><name><surname>Prestwich</surname><given-names>R</given-names></name><name><surname>Turley</surname><given-names>EA</given-names></name></person-group><article-title>Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action</article-title><source>FEBS Lett</source><year>1998</year><volume>440</volume><fpage>444</fpage><lpage>449</lpage><pub-id pub-id-type="pmid">9872419</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>CL</given-names></name><name><surname>Turley</surname><given-names>EA</given-names></name></person-group><article-title>Hyaluronan-Rhamm mediated cell locomotion and signaling in tumorigenesis</article-title><source>J Neurooncol</source><year>1995</year><volume>26</volume><fpage>221</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">8750188</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klewer</surname><given-names>S</given-names></name><name><surname>Yatskievych</surname><given-names>T</given-names></name><name><surname>Pogreba</surname><given-names>K</given-names></name><name><surname>Stevens</surname><given-names>MV</given-names></name><name><surname>Antin</surname><given-names>PB</given-names></name><name><surname>Camenisch</surname><given-names>TD</given-names></name></person-group><article-title>Has2 expression in heart forming regions is independent of BMP signaling</article-title><source>Gene Expr Patterns</source><year>2006</year><volume>6</volume><fpage>462</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">16458617</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Solloway</surname><given-names>MJ</given-names></name><name><surname>Robertson</surname><given-names>EJ</given-names></name></person-group><article-title>Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart</article-title><source>Dev Biol</source><year>2001</year><volume>235</volume><fpage>449</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">11437450</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Solloway</surname><given-names>MJ</given-names></name><name><surname>Robertson</surname><given-names>EJ</given-names></name></person-group><article-title>Early embryonic lethality in Bmp5;Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup</article-title><source>Development</source><year>1999</year><volume>126</volume><fpage>1753</fpage><lpage>1768</lpage><pub-id pub-id-type="pmid">10079236</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Farrington</surname><given-names>JE</given-names></name><name><surname>Muneoka</surname><given-names>K</given-names></name></person-group><article-title>Digit regeneration is regulated by Msx1 and BMP4 in fetal mice</article-title><source>Development</source><year>2003</year><volume>130</volume><fpage>5123</fpage><lpage>5132</lpage><pub-id pub-id-type="pmid">12944425</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>LY</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Hinton</surname><given-names>DR</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>JT</given-names></name><name><surname>Zeng</surname><given-names>A</given-names></name><name><surname>Xie</surname><given-names>JB</given-names></name><name><surname>Snead</surname><given-names>M</given-names></name><name><surname>Shuler</surname><given-names>C</given-names></name><name><surname>Maxson</surname><given-names>RE</given-names><suffix>Jr.</suffix></name><name><surname>Liu</surname><given-names>YH</given-names></name></person-group><article-title>Microphthalmia resulting from Msx2-induced apoptosis in the optic vesicle</article-title><source>Invest Ophthalmol Vis Sci</source><year>2003</year><volume>44</volume><fpage>2404</fpage><lpage>2412</lpage><pub-id pub-id-type="pmid">12766037</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Avniel</surname><given-names>WA</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Jones</surname><given-names>SM</given-names></name><name><surname>Jones</surname><given-names>TA</given-names></name><name><surname>Fermin</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title>Malleal processus brevis is dispensable for normal hearing in mice</article-title><source>Dev Dyn</source><year>2003</year><volume>227</volume><fpage>69</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">12701100</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ganga</surname><given-names>M</given-names></name><name><surname>Espinoza</surname><given-names>HM</given-names></name><name><surname>Cox</surname><given-names>CJ</given-names></name><name><surname>Morton</surname><given-names>L</given-names></name><name><surname>Hjalt</surname><given-names>TA</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Amendt</surname><given-names>BA</given-names></name></person-group><article-title>PITX2 isoform-specific regulation of atrial natriuretic factor expression</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>22437</fpage><lpage>22445</lpage><pub-id pub-id-type="pmid">12692125</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>T</given-names></name><name><surname>Yamagishi</surname><given-names>H</given-names></name><name><surname>Overbeek</surname><given-names>PA</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name><name><surname>Srivastava</surname><given-names>D</given-names></name></person-group><article-title>The bHLH factors, dHAND and eHAND, specify pulmonary and systemic cardiac ventricles independent of left-right sidedness</article-title><source>Dev Biol</source><year>1998</year><volume>196</volume><fpage>228</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">9576835</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitamura</surname><given-names>K</given-names></name><name><surname>Miura</surname><given-names>H</given-names></name><name><surname>Miyagawa-Tomita</surname><given-names>S</given-names></name><name><surname>Yanazawa</surname><given-names>M</given-names></name><name><surname>Katoh-Fukui</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>R</given-names></name><name><surname>Ohuchi</surname><given-names>H</given-names></name><name><surname>Suehiro</surname><given-names>A</given-names></name><name><surname>Motegi</surname><given-names>Y</given-names></name><name><surname>Nakahara</surname><given-names>Y</given-names></name><name><surname>Kondo</surname><given-names>S</given-names></name><name><surname>Yokoyama</surname><given-names>M</given-names></name></person-group><article-title>Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extra- and periocular mesoderm and right pulmonary isomerism</article-title><source>Development</source><year>1999</year><volume>126</volume><fpage>5749</fpage><lpage>5758</lpage><pub-id pub-id-type="pmid">10572050</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abdelwahid</surname><given-names>E</given-names></name><name><surname>Rice</surname><given-names>D</given-names></name><name><surname>Pelliniemi</surname><given-names>LJ</given-names></name><name><surname>Jokinen</surname><given-names>E</given-names></name></person-group><article-title>Overlapping and differential localization of Bmp-2, Bmp-4, Msx-2 and apoptosis in the endocardial cushion and adjacent tissues of the developing mouse heart</article-title><source>Cell Tissue Res</source><year>2001</year><volume>305</volume><fpage>67</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">11512673</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chan-Thomas</surname><given-names>PS</given-names></name><name><surname>Thompson</surname><given-names>RP</given-names></name><name><surname>Robert</surname><given-names>B</given-names></name><name><surname>Yacoub</surname><given-names>MH</given-names></name><name><surname>Barton</surname><given-names>PJR</given-names></name></person-group><article-title>Expression of homeobox genes Msx-1 (Hox-7) and Msx-2 (Hox-8) during cardiac development in the chick</article-title><source>Dev Dyn</source><year>1993</year><volume>197</volume><fpage>203</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">8106021</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>AW</given-names></name><name><surname>Yutzey</surname><given-names>KE</given-names></name></person-group><article-title>NFATc1 expression in the developing heart valves is responsive to the RANKL pathway and is required for endocardial expression of cathepsin K</article-title><source>Dev Biol</source><year>2006</year><volume>292</volume><fpage>407</fpage><lpage>417</lpage><pub-id pub-id-type="pmid">16680826</pub-id></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>MA</given-names></name><name><surname>Kraut</surname><given-names>N</given-names></name><name><surname>Beug</surname><given-names>H</given-names></name></person-group><article-title>Molecular requirements for epithelial-mesenchymal transition during tumor progression</article-title><source>Curr Opin Cell Biol</source><year>2005</year><volume>17</volume><fpage>548</fpage><lpage>558</lpage><pub-id pub-id-type="pmid">16098727</pub-id></citation></ref><ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>Massagu&#x000e9;</surname><given-names>J</given-names></name></person-group><article-title>Epithelial-mesenchymal transitions: twist in development and metastasis</article-title><source>Cell</source><year>2004</year><volume>118</volume><fpage>277</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">15294153</pub-id></citation></ref><ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>KM</given-names></name><name><surname>Pelton</surname><given-names>RW</given-names></name><name><surname>Hogan</surname><given-names>BLM</given-names></name></person-group><article-title>Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A)</article-title><source>Development</source><year>1990</year><volume>109</volume><fpage>833</fpage><lpage>844</lpage><pub-id pub-id-type="pmid">2226202</pub-id></citation></ref><ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schlange</surname><given-names>T</given-names></name><name><surname>Arnold</surname><given-names>HH</given-names></name><name><surname>Brand</surname><given-names>T</given-names></name></person-group><article-title>BMP2 is a positive regulator of Nodal signaling during left-right axis formation in the chicken embryo</article-title><source>Development</source><year>2002</year><volume>129</volume><fpage>3421</fpage><lpage>3429</lpage><pub-id pub-id-type="pmid">12091312</pub-id></citation></ref><ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Rowitch</surname><given-names>DH</given-names></name><name><surname>Soriano</surname><given-names>P</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name><name><surname>Sucov</surname><given-names>HM</given-names></name></person-group><article-title>Fate of the mammalian cardiac neural crest</article-title><source>Development</source><year>2000</year><volume>127</volume><fpage>1607</fpage><lpage>1616</lpage><pub-id pub-id-type="pmid">10725237</pub-id></citation></ref><ref id="B69"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Dijkman</surname><given-names>HBPM</given-names></name><name><surname>Mentzel</surname><given-names>S</given-names></name><name><surname>de Jong</surname><given-names>AS</given-names></name><name><surname>Assmann</surname><given-names>KJM</given-names></name></person-group><article-title>RNA in situ hybridization using DIG-labeled cRNA probes</article-title><source>Procedures for In Situ Hybridization to Chromosomes, Cells, and Tissue Sections</source><year>1995</year><ext-link ext-link-type="uri" xlink:href="http://www.roche-applied-science.com/PROD_INF/MANUALS/InSitu/pdf/ISH_181-188.pdf"/></citation></ref><ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kioussi</surname><given-names>C</given-names></name><name><surname>Briata</surname><given-names>P</given-names></name><name><surname>Baek</surname><given-names>SH</given-names></name><name><surname>Rose</surname><given-names>DW</given-names></name><name><surname>Hamblet</surname><given-names>NS</given-names></name><name><surname>Herman</surname><given-names>T</given-names></name><name><surname>Ohgi</surname><given-names>KA</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Gleiberman</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Brault</surname><given-names>V</given-names></name><name><surname>Ruiz-Lozano</surname><given-names>P</given-names></name><name><surname>Nguyen</surname><given-names>HD</given-names></name><name><surname>Kemler</surname><given-names>R</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>Wynshaw-Boris</surname><given-names>A</given-names></name><name><surname>Rosenfeld</surname><given-names>MG</given-names></name></person-group><article-title>Identification of a Wnt/Dvl/b-Catenin &#x000ae; Pitx2 pathway mediating cell-type-specific proliferation during development</article-title><source>Cell</source><year>2002</year><volume>111</volume><fpage>673</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">12464179</pub-id></citation></ref></ref-list></back></article> 